Spotlight -

Long-Acting Injectable Therapy in the Management of Adult Patients with Schizophrenia|

Major Depressive Disorder

|Videos|May 4, 2020

In an Instant: The Changing Face of Psychiatry

Author(s)P Priyanka, MD

FaceTime, Skype, and other video chat functions are the new normal in the COVID-19 era, and allow this community psychiatrist serve the underserved.

Medical Director for California-based Community Psychiatry, Dr Priyanka shares her experience with telepsychiatry and discusses the transformation of telemedicine before, during, and (hopefully) after COVID-19. Community Psychiatry is an outpatient psychiatric care company with over 120 clinicians in over 40 locations across California.

Newsletter

Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.

Related to this article

covid

October 19th, 2026

New Phase 2 Data on Bezisterim for the Treatment of Long COVID

Phase 2 trial finds bezisterim shows safety and symptom gains in long COVID, with strongest benefits for severe fatigue, PEM, and cognitive issues.

October 12th, 2026

What Makes Us Human? The Role of Psychiatry and the Future DSM

There is a question older than medicine, and perhaps older than philosophy, that psychiatry has largely avoided: What makes us human?

Trending on Psychiatric Times

When Antidepressants Stop Working: Understanding Tachyphylaxis in Clinical Practice

What Do Patient-Level Studies Tell Us About Antidepressants and Suicide Risk?

Evidence-Based Ethical Principles for Long-Acting Injectable Antipsychotic Use

Sleep Disruption and Alzheimer Disease: A Bidirectional, Treatable Relationship

Positive Topline Results From Phase 2 Trial of RAP-219 for the Treatment of Bipolar Mania